Highbridge Capital Management LLC Bio Atla, Inc. Transaction History
Highbridge Capital Management LLC
- $435 Million
- Q4 2024
A detailed history of Highbridge Capital Management LLC transactions in Bio Atla, Inc. stock. As of the latest transaction made, Highbridge Capital Management LLC holds 2,509,626 shares of BCAB stock, worth $1.03 Million. This represents 0.34% of its overall portfolio holdings.
Number of Shares
2,509,626Holding current value
$1.03 Million% of portfolio
0.34%Shares
1 transactions
Others Institutions Holding BCAB
# of Institutions
66Shares Held
20.3MCall Options Held
500Put Options Held
33.5K-
Israel Englander Millennium Management LLC | New York, Ny2.66MShares$1.09 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.52MShares$1.03 Million0.38% of portfolio
-
Morgan Stanley New York, NY1.86MShares$761,8520.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.83MShares$751,3150.0% of portfolio
-
Tang Capital Management LLC San Diego, CA874KShares$358,3710.13% of portfolio
About BioAtla, Inc.
- Ticker BCAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,304,100
- Market Cap $14.9M
- Description
- BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...